Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT00270816

Interferon ß-1b Treatment by Cyclical Administration

Effect of Cyclical Administration of Interferon β-1b in Multiple Sclerosis - Comparison With Normal Dose.

Sponsor: Italian Multiple Sclerosis Foundation

Interventions Interferon ß-1b Interferon-ß-1b

Updated 7 times since 2017 Last updated: Dec 17, 2018 Started: Nov 30, 2005 Primary completion: Aug 31, 2010 Completion: Jan 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Multiple Sclerosis and is currently completed. Italian Multiple Sclerosis Foundation leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jan 2019 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2019 [monthly]

Completed PHASE2_PHASE3

▶ Show 2 earlier versions

Jan 2018 — Jun 2018 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jan 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Italian Multiple Sclerosis Foundation
S. Andrea Hospital

Data source: S. Andrea Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy